| HOME >> BIOLOGY >> TECHNOLOGY |
Investor and Financial Contacts:
Eileen Pattinson
Investor Relations
(760) 603-7208
LIFE TECHNOLOGIES CORPORATIONCONSOLIDATED STATEMENTS OF OPERATIONSAND RECONCILIATION OF NON-GAAP ADJUSTMENTS(1)For the three monthsFor the three months(in thousands, except per share data)
ended June 30, 2011ended June 30, 2010(unaudited)GAAPAdjustmentsNon-GAAPGAAPAdjustmentsNon-GAAPRevenues$
941,135
$
3,638
(2)
$
944,773$
903,732
$
,786
(2)
$
905,518Cost of revenues
340,075
(2,094)
(3)
337,981293,000
(313)
(3)
292,687Purchased intangibles amortization
76,476
(76,476)
(4)-70,051
(70,051)
(4)
-Gross profit
524,584
82,208606,792540,681
72,150612,831Gross margin
55.7%64.2%59.8%67.7%Operating expenses:Selling, general and administrative
254,764
(1,452)
(5)
253,312252,813
(1,914)
(5)
250,899Research and development
91,085
(469)
(5)
90,61690,344
(684)
(5)
89,660Purchased in-process research and development
-
--1,650
(1,650)
(4)
-Business consolidation costs
18,666
(18,666)
(6)-23,446
(23,446)
(6)
-Total operating expenses
364,515
(20,587)343,928368,253
(27,694)340,559Operating income
160,069
102,795262,864172,428
99,844272,272Operating margin
17.0%27.8%19.1%30.1%Interest income
1,153
-1,1531,105
-1,105Interest expense
(42,774)
8,833
(7)
(33,941)(39,309)
11,337
'/>"/>| SOURCE Life Technologies Corporation Copyright©2010 PR Newswire. All rights reserved |